Abstract
In this study, MCM-41 mesoporous silica nanoparticles were successfully synthesized by the condensation of a tetraorthosilicate precursor on a template self-assembled by cetyltrimethylammonium bromide in alkaline. The small-angle x-ray diffraction patterns of MCM-41 indicate that silica nanoparticles possess hexagonal structures with a high degree of structural ordering. Transmission electron microscopy images show that the size of the MCM-41 particles is around 100-120 nm, and the pore sizes range from 2 nm to 4 nm. In addition, the specific surface area of MCM-41 obtained by Brunauer–Emmett–Teller analysis is as high as 987 m2.g−1 and the pore size extracted from nitrogen physical adsorption isotherms is in accordance with the TEM result. Thermogravimetric analysis, Fourier-transform infrared spectroscopy, Zeta potential measurements and photoluminescence measurements show that 3-aminopropyltriethoxysilane (APTES) and doxorubicin were grafted and loaded successfully onto MCM-41 nanoparticles. An assay on fibroblasts, A549 and doxorubicin-resistant A549/DOX cells indicates that the prepared MCM41 grafting APTES nanoparticles are safe to normal cells and toxic to cancer cells in vitro.
Graphic abstract
Similar content being viewed by others
References
WHO, Who Report on Cancer (Geneva: WHO, 2020).
H. Barabadi, O. Hosseini, K. Damavandi Kamali, F. Jazayeri Shoushtari, M. Rashedi, H. Haghi-Aminjan, and M. Saravanan, J. Clust. Sci. 31, 1 (2020).
H. Barabadi, H. Vahidi, K. Damavandi Kamali, O. Hosseini, M.A. Mahjoub, M. Rashedi, F. Jazayeri Shoushtari, and M. Saravanan, J. Clust. Sci. 31, 323 (2020).
N. Iturrioz-Rodríguez, M.A. Correa-Duarte, and M.L. Fanarraga, Int. J. Nanomedicine 14, 3389 (2019).
Y.J. Cheng, S.Y. Qin, Y.H. Ma, X.S. Chen, A.Q. Zhang, X.Z. Zhang, and A.C.S. Biomater, Sci. Eng. 5, 1878 (2019).
Y. Zhang, J. Xu, and R. Soc, Open Sci. 5, 170986 (2018).
R. Narayan, U.Y. Nayak, A.M. Raichur, and S. Garg, Pharmaceutics 10, 1 (2018).
H. Barabadi, Z. Alizadeh, M.T. Rahimi, A. Barac, A.E. Maraolo, L.J. Robertson, A. Masjedi, F. Shahrivar, and E. Ahmadpour, Biol. Med. 18, 221 (2019).
H. Barabadi, K. Damavandi Kamali, F. Jazayeri Shoushtari, B. Tajani, M.A. Mahjoub, A. Alizadeh, and M. Saravanan, J. Clust. Sci. 30, 1375 (2019).
H. Barabadi, B. Tajani, M. Moradi, K. Damavandi Kamali, R. Meena, S. Honary, M.A. Mahjoub, and M. Saravanan, J. Clust. Sci. 30, 843 (2019).
N.P.E. Barry, and P.J. Sadler, ACS Nano 7, 5654 (2013).
H. Barabadi, H. Vahidi, K. Damavandi Kamali, M. Rashedi, O. Hosseini, A.R. GolnaraghicGhomi, and M. Saravanan, J. Clust. Sci. 31, 311 (2020).
H. Barabadi, H. Vahidi, K. Damavandi Kamali, M. Rashedi, and M. Saravanan, J. Clust. Sci. 31, 659 (2020).
C. Bharti, N. Gulati, U. Nagaich, and A. Pal, Int. J. Pharm. Investig. 5, 124 (2015).
P. Krasucka and J. Goworek, Ann. Univ. Mariae Curie-Sklodowska, Sect. AA – Chem. 70, 45 (2016).
Z. Li, Y. Zhang, and N. Feng, Expert Opin. Drug Deliv. 16, 219 (2019).
M. Colilla, B. González, and M. Vallet-Regí, Biomater. Sci. 1, 114 (2013).
Y. Song, Y.L. Qien, X. Zhe, and Z. Liu, Int J Nanomed. 12, 87 (2017).
M. Karimi, H. Mirshekari, M. Aliakbari, P.S. Zangabad, and M.R. Hamblin, Nanotechnol. Rev. 5, 195 (2015).
Sun and Xiaoxing, Grad. Theses Diss. (2012).
F. Marcucci, and A. Corti, Adv. Drug Deliv. Rev. 64, 53 (2012).
C. Xu, C. Lei, and C. Yu, Front. Chem. 7, 1 (2019).
E.D.M. Isa, H. Ahmad, and M.B.A. Rahman, J. Nanomater. 2019, 4982054 (2019).
N.S. Hosseini Motlagh, P. Parvin, M. Refahizadeh, and A. Bavali, Appl. Opt. 56, 7498 (2017).
Y. Wang, Y. Sun, J. Wang, Y. Yang, Y. Li, Y. Yuan, C. Liu, and A.C.S. Appl, Mater. Interfaces 8, 17166 (2016).
A. Tukappa, A. Ultimo, C. De La Torre, T. Pardo, F. Sancenón, and R. Martínez-Máñez, Langmuir 32, 8507 (2016).
L.V.M. Hung, Y.W. Song, and S.K. Cho, Mar. Drugs 16, 1 (2018).
J.Y. Moon, L.V.M. Hung, T. Unno, and S.K. Cho, Nutrients 10, 1829 (2018).
H. Chen, S. Fu, L. Fu, H. Yang, and D. Chen, Minerals 9, 1 (2019).
D.P. Wijaya, W. Trisunaryanti, K.D. Triyono, and M.F. Marsuki, J. Chem. 34, 1847 (2018).
M. Jaroniec, M. Kruk, H.J. Shin, R. Ryoo, Y. Sakamoto, and O. Terasaki, Microporous Mesoporous Mater. 48, 127 (2001).
F. Havasi, A. Ghorbani-Choghamarani, and F. Nikpour, New J. Chem. 39, 6504 (2015).
Y. Dai, D. Yang, P. Ma, X. Kang, X. Zhang, C. Li, Z. Hou, Z. Cheng, and J. Lin, Biomaterials 33, 8704 (2012).
S. Shah, A. Chandra, A. Kaur, N. Sabnis, A. Lacko, Z. Gryczynski, R. Fudala, and I. Gryczynski, J. Photochem. Photobiol. B Biol. 170, 65 (2017).
T. Kong, L. Hao, Y. Wei, X. Cai, and B. Zhu, Cell Prolif. 51, 1 (2018).
N.V. Roik, L.A. Belyakova, and M.O. Dziazko, Adsorpt. Sci. Technol. 35, 86 (2017).
H. Vahidi, H. Barabadi, and M. Saravanan, J. Clust. Sci. 31, 301 (2020).
Y. Zhao, X. Sun, G. Zhang, B.G. Trewyn, I.I. Slowing, and V.S.Y. Lin, ACS Nano 5, 1366 (2011).
L. Chen, J. Liu, Y. Zhang, G. Zhang, Y. Kang, A. Chen, X. Feng, and L. Shao, Nanomedicine 13, 1939 (2018).
Acknowledgments
This research is funded by the Vietnam National University, Ho Chi Minh City (VNU-HCM) under Grant Number C2018-18-26.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dau, T.A.N., Le, V.M.H., Pham, T.K.H. et al. Surface Functionalization of Doxorubicin loaded MCM-41 Mesoporous Silica Nanoparticles by 3-Aminopropyltriethoxysilane for Selective Anticancer 9 Effect on A549 and A549/DOX Cells. J. Electron. Mater. 50, 2932–2939 (2021). https://doi.org/10.1007/s11664-021-08813-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11664-021-08813-y